Table 3 Top canonical pathways affected by miR-34c
From: The tumour suppressor miR-34c targets MET in prostate cancer cells
Ingenuity canonical pathways | P-value |
|---|---|
Antigen presentation pathway | 2.5E-05 |
Interferon signalling | 9.6E-05 |
Prolactin signalling | 5.3E-04 |
Erythropoietin signalling | 9.6E-04 |
Hepatic fibrosis / hepatic stellate cell activation | 0.0013 |
p70S6K signaling | 0.0020 |
Role of pattern recognition receptors in recognition of bacteria/viruses | 0.0026 |
Arginine and proline metabolism | 0.0028 |
Growth hormone signalling | 0.0030 |
NF-κB signaling | 0.0052 |
Sphingolipid metabolism | 0.0072 |
HGF signalling | 0.0087 |
Pentose phosphate pathway | 0.0091 |
